secwatch.observer — SEC 8-K summary
======================================

Issuer:     WATERS CORP /DE/ (WAT)
CIK:        0001000697
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001193125-24-200650
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Waters Corporation appoints Heather Knight to Board of Directors
----------------------------------------------------------------

- Appointed Heather Knight effective Aug 14, 2024; Board size increased from 9 to 10.
- Knight is EVP and Group President, Medical Products and Therapies at Baxter International.
- Initial equity grant valued at $91,666 (50% RSU, 50% option), vesting on first anniversary.
- Prorated cash retainer of $54,130 until 2025 AGM; standard non-employee director compensation.
- Knight brings nearly three decades of global pharma and med device leadership experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000697/000119312524200650/0001193125-24-200650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000697/000119312524200650/d879337d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-200650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer